Burney Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Sell
4,298
-20
-0.5% -$7.42K 0.04% 267
2026
Q1
$1.26M Sell
4,318
-73
-2% -$24K 0.04% 285
2025
Q4
$1.54M Sell
4,391
-1,329
-23% -$449K 0.05% 281
2025
Q3
$1.85M Sell
5,720
-453
-7% -$141K 0.06% 242
2025
Q2
$2.4M Sell
6,173
-346
-5% -$139K 0.08% 206
2025
Q1
$2.84M Sell
6,519
-321
-5% -$129K 0.1% 174
2024
Q4
$2.52M Sell
6,840
-498
-7% -$208K 0.09% 189
2024
Q3
$3.82M Sell
7,338
-1,320
-15% -$705K 0.14% 159
2024
Q2
$4.69M Sell
8,658
-252
-3% -$133K 0.18% 135
2024
Q1
$4.62M Buy
8,910
+28
+0.3% +$13.9K 0.18% 142
2023
Q4
$4.19M Sell
8,882
-265
-3% -$123K 0.18% 146
2023
Q3
$3.98M Buy
9,147
+56
+0.6% +$25.4K 0.19% 142
2023
Q2
$4.04M Sell
9,091
-575
-6% -$265K 0.19% 143
2023
Q1
$4.44M Buy
9,666
+2,268
+31% +$1.08M 0.22% 133
2022
Q4
$3.79M Buy
7,398
+84
+1% +$42.6K 0.19% 145
2022
Q3
$3.32M Sell
7,314
-180
-2% -$86.1K 0.18% 148
2022
Q2
$3.62M Sell
7,494
-50
-0.7% -$24.7K 0.19% 139
2022
Q1
$3.71M Sell
7,544
-45
-0.6% -$20.6K 0.17% 156
2021
Q4
$3.52M Buy
7,589
+126
+2% +$53K 0.15% 166
2021
Q3
$2.78M Sell
7,463
-128
-2% -$48.6K 0.13% 183
2021
Q2
$2.9M Sell
7,591
-525
-6% -$201K 0.13% 189
2021
Q1
$2.91M Buy
8,116
+6
+0.1% +$1.93K 0.14% 180
2020
Q4
$2.6M Sell
8,110
-1,896
-19% -$582K 0.14% 182
2020
Q3
$2.69M Sell
10,006
-315
-3% -$84.8K 0.17% 173
2020
Q2
$2.71M Sell
10,321
-432
-4% -$115K 0.18% 162
2020
Q1
$2.44M Sell
10,753
-944
-8% -$257K 0.19% 145
2019
Q4
$3.53M Buy
11,697
+3,336
+40% +$918K 0.19% 133
2019
Q3
$2.01M Sell
8,361
-302
-3% -$82.7K 0.12% 195
2019
Q2
$2.44M Buy
8,663
+1,642
+23% +$449K 0.15% 182
2019
Q1
$2.02M Sell
7,021
-214
-3% -$61.9K 0.12% 187
2018
Q4
$1.9M Buy
7,235
+1,684
+30% +$463K 0.13% 182
2018
Q3
$1.52M Sell
5,551
-1,890
-25% -$491K 0.09% 219
2018
Q2
$1.77M Buy
7,441
+1,739
+30% +$403K 0.1% 209
2018
Q1
$1.25M Sell
5,702
-1,607
-22% -$377K 0.08% 223
2017
Q4
$1.65M Buy
7,309
+1,494
+26% +$318K 0.09% 207
2017
Q3
$1.1M Sell
5,815
-245
-4% -$46.6K 0.07% 220
2017
Q2
$1.13M Sell
6,060
-790
-12% -$142K 0.07% 214
2017
Q1
$1.13M Sell
6,850
-280
-4% -$44.5K 0.07% 208
2016
Q4
$1.02M Sell
7,130
-620
-8% -$83K 0.07% 207
2016
Q3
$987K Sell
7,750
-285
-4% -$36.8K 0.07% 203
2016
Q2
$1.05M Sell
8,035
-379
-5% -$51.9K 0.08% 203
2016
Q1
$1.17M Sell
8,414
-454
-5% -$60.7K 0.09% 194
2015
Q4
$1.24M Buy
8,868
+1,165
+15% +$160K 0.09% 190
2015
Q3
$1.08M Sell
7,703
-785
-9% -$118K 0.08% 191
2015
Q2
$1.39M Sell
8,488
-281
-3% -$44.9K 0.09% 185
2015
Q1
$1.35M Buy
8,769
+754
+9% +$107K 0.09% 198
2014
Q4
$1.01M Buy
8,015
+566
+8% +$69.9K 0.08% 208
2014
Q3
$891K Hold
7,449
0.08% 216
2014
Q2
$802K Buy
7,449
+365
+5% +$37.6K 0.07% 227
2014
Q1
$705K Sell
7,084
-20
-0.3% -$1.81K 0.06% 238
2013
Q4
$656K Sell
7,104
-215
-3% -$19.1K 0.06% 246
2013
Q3
$612K Sell
7,319
-195
-3% -$16.7K 0.07% 247
2013
Q2
$615K Buy
+7,514
New +$562K 0.08% 231

Other funds holding ELV

Burney Company's ELV Position: Q2 2026 in Review

Burney Company reduced its Elevance Health (ELV) stake by 0.46% in Q2 2026, selling an estimated $7.42K and leaving 4,298 shares worth $1.66M. The position accounts for 0.04% of the portfolio, ranked #267.

Burney Company first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.69M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Burney Company held 4,298 shares of Elevance Health worth $1.66M as of Q2 2026.
  • Burney Company sold 20 Elevance Health shares in Q2 2026, an estimated $7.42K.
  • Elevance Health made up 0.04% of Burney Company's portfolio in Q2 2026, its #267 holding.
  • Burney Company first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Burney Company's Elevance Health position peaked at $4.69M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.